Literature DB >> 31243619

Central and peripheral steady-state visual evoked potentials in children with optic pathway gliomas.

Sarah Zakaib Rassi1, Luis H Ospina2, Ariane Bochereau3, Yvan Samson4, Sébastien Perreault5, Dave Saint-Amour6,7,8.   

Abstract

PURPOSE: Treatment of optic pathway gliomas is prompted by neuroradiological evidence of tumor growth, usually associated with progressive visual loss. Despite therapy, approximately 40% will show visual deterioration. Treatment outcome is largely based on the preservation of vision. However, current visual function assessment is often unreliable in children with optic pathway gliomas who have limited collaboration. Thus, there is a need for new clinical tools to evaluate visual functions in these children. The aim of the study was to assess the value of steady-state visual evoked potentials as a tool to assess function in the central and peripheral visual fields of children with optic pathway gliomas.
METHOD: Ten patients with optic pathway gliomas and 33 healthy controls (ages 3 to 18 years) were tested using steady-state visual evoked potentials. The dartboard stimulus consisted of one central circle alternating at 16 reversals/s and one peripheral hoop alternating at 14.4 reversals/s, separated by a hoop of gray space. It was presented monocularly at 30% and 96% contrasts.
RESULTS: Results indicated that central signal-to-noise ratios were significantly lower in children with optic pathway gliomas compared to controls. However, no significant group difference was detected in the peripheral visual field.
CONCLUSION: Steady-state visual evoked potentials could eventually be implemented in the clinical assessment and follow-up of central visual field deficits in uncooperative or nonverbal children but seem to have limited usefulness for evaluation of peripheral visual field deficits. Additional studies are needed to identify testing parameters for full visual field assessment.

Entities:  

Keywords:  Optic nerve; Optic pathway glioma; Steady-state visual evoked potential; Visual field assessment

Mesh:

Year:  2019        PMID: 31243619     DOI: 10.1007/s10633-019-09703-9

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  36 in total

1.  Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood.

Authors:  Angelo Ammendola; Gianluca Ciccone; Eduardo Ammendola
Journal:  Pediatr Neurol       Date:  2006-04       Impact factor: 3.372

Review 2.  Optic pathway gliomas.

Authors:  Christopher D Jahraus; Nancy J Tarbell
Journal:  Pediatr Blood Cancer       Date:  2006-05-01       Impact factor: 3.167

Review 3.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

4.  Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.

Authors:  Viviane Robert-Boire; Lorena Rosca; Yvan Samson; Luis H Ospina; Sébastien Perreault
Journal:  Pediatr Neurol       Date:  2017-07-06       Impact factor: 3.372

5.  Retinotopic mapping of the peripheral visual field to human visual cortex by functional magnetic resonance imaging.

Authors:  Jinglong Wu; Tianyi Yan; Zhen Zhang; Fengzhe Jin; Qiyong Guo
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

6.  Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children.

Authors:  G F A Harding; E L Spencer; J M Wild; M Conway; R L Bohn
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

7.  A frequency-tagging electrophysiological method to identify central and peripheral visual field deficits.

Authors:  Noémie Hébert-Lalonde; Lionel Carmant; Dima Safi; Marie-Sylvie Roy; Maryse Lassonde; Dave Saint-Amour
Journal:  Doc Ophthalmol       Date:  2014-05-10       Impact factor: 2.379

8.  The role of the multifocal visual evoked potential (mfVEP) latency in understanding optic nerve and retinal diseases.

Authors:  Donald C Hood; John Y Chen; E Bo Yang; Chris Rodarte; Adam S Wenick; Tomas M Grippo; Jeffrey G Odel; Robert Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings.

Authors:  Benedetto Falsini; Lucia Ziccardi; Ilaria Lazzareschi; Antonio Ruggiero; Luca Placentino; Anna Dickmann; Lucia Liotti; Marco Piccardi; Emilio Balestrazzi; Cesare Colosimo; Concezio Di Rocco; Riccardo Riccardi
Journal:  J Neurooncol       Date:  2008-02-02       Impact factor: 4.130

10.  Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.

Authors:  C Kuenzle; M Weissert; E Roulet; H Bode; S Schefer; T Huisman; K Landau; E Boltshauser
Journal:  Neuropediatrics       Date:  1994-12       Impact factor: 1.947

View more
  1 in total

1.  Steady-state visual evoked potentials in children with neurofibromatosis type 1: associations with behavioral rating scales and impact of psychostimulant medication.

Authors:  Eve Lalancette; Audrey-Rose Charlebois-Poirier; Kristian Agbogba; Inga Sophia Knoth; Emily J H Jones; Luke Mason; Sébastien Perreault; Sarah Lippé
Journal:  J Neurodev Disord       Date:  2022-07-22       Impact factor: 4.074

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.